Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: The influence of LCPUFA on neural development, aging, and neurodegeneration

Progress in Lipid Research

Volumn 53, Issue 1, 2014, Pages 1-17

  Janssen, Carola I F ^a   Kiliaan, Amanda J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Animal studies; Clinical studies; Long chain polyunsaturated fatty acids; Neural development; Neurodegeneration

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LONG CHAIN POLYSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; ATTENTION DEFICIT DISORDER; AUTISM; BRAIN PERFUSION; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; DEVELOPMENTAL STAGE; DISEASE ASSOCIATION; FATTY ACID ANALYSIS; GENETIC ASSOCIATION; HUMAN; HYPERTENSION; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; SENESCENCE; SENSORIMOTOR INTEGRATION;

ANIMALIA; RODENTIA;

1,2 DIACYLGLYCEROL CHOLINE PHOSPHOTRANSFERASE; 1-METHYL-4-PHENYL-1, 2, 3, 6-TETRAHYDROPYRIDINE; 5-LIPOXYGENASE; 5-LOX; ACUTE MYOCARDIAL INFARCTION; AD; ADAS-COG; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADHD; ADP; ALA; ALZHEIMER'S DISEASE; AMI; ANIMAL STUDIES; ARA; ARACHIDONIC ACID; ATP; ATTENTION DEFICIT HYPERACTIVITY DISORDER; AΒ; B12; B6; BAYLEY SCALES OF INFANT DEVELOPMENT; BBB; BDNF; BLOOD BRAIN BARRIER; BRAIN-DERIVED NEUROTROPHIC FACTOR; BSID; CAMP; CAMP RESPONSE ELEMENT BINDING PROTEIN; CDP-CHOLINE; CDR; CHOLINE KINASE; CIBIC-PLUS; CK; CLINICAL DEMENTIA RATING; CLINICAL STUDIES; CLINICIAN'S INTERVIEW-BASED IMPRESSION OF CHANGE SCALE WHICH INCLUDED CAREGIVER-SUPPLIED INFORMATION; COGNITIVE SUBSCALE OF THE ALZHEIMER'S DISEASE ASSESSMENT SCALE; COX; CPT; CREB; CT; CTP; CYCLIC ADENOSINE MONOPHOSPHATE; CYCLOOXYGENASE; CYTIDINE DIPHOSPHATE CHOLINE; CYTIDINE TRIPHOSPHATE; CYTIDINE TRIPHOSPHATE-PHOSPHOCHOLINE CYTIDYL TRANSFERASE; DAG; DBS; DEEP BRAIN STIMULATION; DHA; DIABETES MELLITUS TYPE 2; DIACYLGLYCEROL; DMII; DOCOSAHEXAENOIC ACID; EICOSAPENTAENOIC ACID; EPA; FADS; FATTY ACID DESATURASE; GDNF; GLA; GLIAL CELL-DERIVED NEUROTROPHIC FACTOR; I-DIHYDROXYPHENYLALANINE; I-DOPA; INTELLIGENCE QUOTIENT; IQ; LA; LCPUFA; LDL; LEUKOTRIENES; LINOLEIC ACID; LONG-CHAIN POLYUNSATURATED FATTY ACIDS; LOW DENSITY LIPOPROTEIN; LT; MCI; MDI; MENTAL DEVELOPMENT INDEX; METABOLIC SYNDROME; METS; MILD COGNITIVE IMPAIRMENT; MINI-MENTAL STATE EXAMINATION; MMSE; MPTP; N-3 PUFA; N-6 PUFA; NEURAL DEVELOPMENT; NEURODEGENERATION; NEUROPROTECTIN D1; NEUROPSYCHIATRIC INVENTORY; NPD1; NPI; OMEGA-3 POLYUNSATURATED FATTY ACIDS; OMEGA-6 POLYUNSATURATED FATTY ACIDS; P.P.; PARKINSON'S DISEASE; PC; PD; PDI; PE; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; PG; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; POST PARTUM; PPAR; PROSTAGLANDINS; PS; PSYCHOMOTOR DEVELOPMENT INDEX; RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED; RAR; RBANS; RDBPC; REPEATABLE BATTERY FOR THE ASSESSMENT OF NEUROPSYCHOLOGICAL STATUS; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; RXR; SATURATED FATTY ACIDS; SFA; SNPC; SUBSTANTIA NIGRA PARS COMPACTA; THROMBOXANES; TRK B; TX; TYROSINE KINASE B; URIDINE TRIPHOSPHATE; UTP; VEP; VERY LOW DENSITY LIPOPROTEIN; VISUAL EVOKED POTENTIAL; VITAMIN B12; VITAMIN B6; VLDL; Α-LINOLENIC ACID; Β-AMYLOID; Γ LINOLENIC ACID;

AGING; ANIMALS; FATTY ACIDS, UNSATURATED; HUMANS; NERVOUS SYSTEM; NEURODEGENERATIVE DISEASES; NEUROGENESIS;

EID: 84887150216     PISSN: 01637827     EISSN: 18732194     Source Type: Journal    
DOI: 10.1016/j.plipres.2013.10.002     Document Type: Review

References (241)

1. F.A.J. Muskiet Pathophysiology and evolutionary aspects of dietary fats and long-chain polyunsaturated fatty acids across the life cycle J.P. Montmayeur, J. le Coutre, Fat detection: taste, texture, and post ingestive effects 2010 CRC Press Boca Raton (FL)
2. H.O. Bang, J. Dyerberg, and A.B. Nielsen Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos Lancet 1 1971 1143 1145
3. H.O. Bang, J. Dyerberg, and H.M. Sinclair The composition of the Eskimo food in north western Greenland Am J Clin Nutr 33 1980 2657 2661
4. R. Estruch, E. Ros, J. Salas-Salvado, M.I. Covas, D. Corella, and F. Aros Primary prevention of cardiovascular disease with a Mediterranean diet N Engl J Med 368 2013 1279 1290
5. M. Guasch-Ferre, M. Bullo, M.A. Martinez-Gonzalez, E. Ros, D. Corella, and R. Estruch Frequency of nut consumption and mortality risk in the PREDIMED nutrition intervention trial BMC Med 11 2013 164
6. M.P. Hoevenaar-Blom, A.C. Nooyens, D. Kromhout, A.M. Spijkerman, J.W. Beulens, and Y.T. van der Schouw Mediterranean style diet and 12-year incidence of cardiovascular diseases: the EPIC-NL cohort study PLoS ONE 7 2012 e45458
7. S. Renaud, M. de Lorgeril, J. Delaye, J. Guidollet, F. Jacquard, and N. Mamelle Cretan Mediterranean diet for prevention of coronary heart disease Am J Clin Nutr 61 1995 1360S 1367S
8. C. Feart, C. Samieri, V. Rondeau, H. Amieva, F. Portet, and J.F. Dartigues Adherence to a Mediterranean diet, cognitive decline, and risk of dementia JAMA 302 2009 638 648
9. D. Jansen, V. Zerbi, C.I. Janssen, D. van Rooij, B. Zinnhardt, and P.J. Dederen Impact of a multi-nutrient diet on cognition, brain metabolism, hemodynamics, and plasticity in apoE4 carrier and apoE knockout mice Brain Struct Funct 2013 10.1007/s00429-013-0606-7
10. A. Nilsson, K. Radeborg, I. Salo, and I. Bjorck Effects of supplementation with n-3 polyunsaturated fatty acids on cognitive performance and cardiometabolic risk markers in healthy 51 to 72 years old subjects: a randomized controlled cross-over study Nutr J 11 2012 99
11. C. Agostoni Role of long-chain polyunsaturated fatty acids in the first year of life J Pediatr Gastroenterol Nutr 47 2008 S41 S44 10.1097/01.mpg. 0000338811.52062.b2
12. J. Belkind-Gerson, A. Carreon-Rodriguez, C.O. Contreras-Ochoa, S. Estrada-Mondaca, and M.S. Parra-Cabrera Fatty Acids Neurodevelop 47 2008 S7 S9 10.1097/MPG.0b013e3181818e3f
13. F. Calon, and G. Cole Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies Prostaglandins Leukot Essent Fatty Acids 77 2007 287 293
14. U.N. Das Folic acid and polyunsaturated fatty acids improve cognitive function and prevent depression, dementia, and Alzheimer's disease - but how and why? Prostaglandins Leukot Essent Fatty Acids 78 2008 11 19
15. Y. Freund-Levi, H. Basun, T. Cederholm, G. Faxen-Irving, A. Garlind, and M. Grut Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms Int J Geriatr Psych 23 2008 161 169
16. C.R. Hooijmans, F. Rutters, P.J. Dederen, G. Gambarota, A. Veltien, and T. van Groen Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD) Neurobiol Dis 28 2007 16 29
17. S.M. Innis Dietary omega 3 fatty acids and the developing brain Brain Res 1237 2008 35 43
18. S.A. van Goor, D.A. Dijck-Brouwer, B. Doornbos, J.J. Erwich, A. Schaafsma, and F.A. Muskiet Supplementation of DHA but not DHA with arachidonic acid during pregnancy and lactation influences general movement quality in 12-week-old term infants Br J Nutr 103 2010 235 242
19. A. Coluccia, P. Borracci, G. Renna, A. Giustino, T. Latronico, and P. Riccio Developmental omega-3 supplementation improves motor skills in juvenile-adult rats Int J Dev Neurosci 27 2009 599 605
20. I. Fedorova, N. Hussein, M.H. Baumann, C. Di Martino, and N. Salem Jr. An n-3 fatty acid deficiency impairs rat spatial learning in the Barnes maze Behav Neurosci 123 2009 196 205
21. A.J. Richardson Omega-3 fatty acids in ADHD and related neurodevelopmental disorders Int Rev Psych (Abingdon, England) 18 2006 155 172
22. R.K. McNamara, R. Jandacek, T. Rider, P. Tso, Y. Dwivedi, and G.N. Pandey Adult medication-free schizophrenic patients exhibit long-chain omega-3 fatty acid deficiency: implications for cardiovascular disease risk Cardiovasc Psych Neurol 2013 2013 796462
23. M.M. Sethom, S. Fares, N. Bouaziz, W. Melki, R. Jemaa, and M. Feki Polyunsaturated fatty acids deficits are associated with psychotic state and negative symptoms in patients with schizophrenia Prostaglandins Leukot Essent Fatty Acids 83 2010 131 136
24. I. Fedorova, A.R. Alvheim, N. Hussein, and N. Salem Jr. Deficit in prepulse inhibition in mice caused by dietary n-3 fatty acid deficiency Behav Neurosci 123 2009 1218 1225
25. G. Mathieu, C. Oualian, I. Denis, M. Lavialle, P. Gisquet-Verrier, and S. Vancassel Dietary n-3 polyunsaturated fatty acid deprivation together with early maternal separation increases anxiety and vulnerability to stress in adult rats Prostaglandins Leukot Essent Fatty Acids 85 2011 129 136
26. P.J. Kamphuis, F.R. Verhey, M.G. Olde Rikkert, J.W. Twisk, S.H. Swinkels, and P. Scheltens Efficacy of a medical food on cognition in Alzheimer's disease: results from secondary analyses of a randomized, controlled trial J Nutr Health Aging 15 2011 720 724
27. P. Scheltens, P.J. Kamphuis, F.R. Verhey, M.G. Olde Rikkert, R.J. Wurtman, and D. Wilkinson Efficacy of a medical food in mild Alzheimer's disease: a randomized, controlled trial Alzheimers Dement 6 2010 [1-10.e1]
28. R.C. Shah Medical foods for Alzheimer's disease Drugs Aging 28 2011 421 428
29. M.J.T. Fitzgerald, and J. Folan Curran Clinical neuroanatomy and related neuroscience 4th ed. 2002 WB Saunders Edinburgh
30. R. Larsen, K.E. Eilertsen, and E.O. Elvevoll Health benefits of marine foods and ingredients Biotechnol Adv 29 2011 508 518
31. D.I. Mostofsky, S. Yehuda, and N. Salem Jr. Fatty acids: physiological and behavioral functions A. Bendich, Nutrition and health 2001 Humana Press Inc. Totowa
32. L. Dagai, R. Peri-Naor, and R.Z. Birk Docosahexaenoic acid significantly stimulates immediate early response genes and neurite outgrowth Neurochem Res 34 2009 867 875
33. B. Koletzko, E. Lien, C. Agostoni, H. Böhles, C. Campoy, and I. Cetin The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations J Perinat Med 36 2008 5 14
34. M. Hadders-Algra The role of long-chain polyunsaturated fatty acids (LCPUFA) in growth and development Adv Exp Med Biol 569 2005 80 94
35. I.B. Helland, L. Smith, K. Saarem, O.D. Saugstad, and C.A. Drevon Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age Pediatrics 111 2003 e39 e44
36. D.R. Hoffman, J.A. Boettcher, and D.A. Diersen-Schade Toward optimizing vision and cognition in term infants by dietary docosahexaenoic and arachidonic acid supplementation: a review of randomized controlled trials Prostaglandins Leukot Essent Fatty Acids 81 2009 151 158
37. R.J. Wurtman, M. Cansev, T. Sakamoto, and I.H. Ulus Use of phosphatide precursors to promote synaptogenesis Annu Rev Nutr 29 2009 59 87
38. E.P. Kennedy, and S.B. Weiss The function of cytidine coenzymes in the biosynthesis of phospholipides J Biol Chem 222 1956 193 214
39. P.S. Sastry Lipids of nervous tissue: composition and metabolism Prog Lipid Res 24 1985 69 176
40. A.P. Simopoulos The omega-6/omega-3 fatty acid ratio, genetic variation, and cardiovascular disease Asia-Pac J Clin Nutr 17 Suppl. 1 2008 131 134
41. L. Xie, and S.M. Innis Genetic variants of the FADS1 FADS2 gene cluster are associated with altered (n-6) and (n-3) essential fatty acids in plasma and erythrocyte phospholipids in women during pregnancy and in breast milk during lactation J Nutr 138 2008 2222 2228
42. P. Rzehak, J. Heinrich, N. Klopp, L. Schaeffer, S. Hoff, and G. Wolfram Evidence for an association between genetic variants of the fatty acid desaturase 1 fatty acid desaturase 2 (FADS1 FADS2) gene cluster and the fatty acid composition of erythrocyte membranes Br J Nutr 101 2009 20 26
43. G. Schmitz, and J. Ecker The opposing effects of n-3 and n-6 fatty acids Prog Lipid Res 47 2008 147 155
44. R.A. Gibson, B. Muhlhausler, and M. Makrides Conversion of linoleic acid and alpha-linolenic acid to long-chain polyunsaturated fatty acids (LCPUFAs), with a focus on pregnancy, lactation and the first 2 years of life Maternal Child Nutr 7 Suppl. 2 2011 17 26
45. L. Schaeffer, H. Gohlke, M. Muller, I.M. Heid, L.J. Palmer, and I. Kompauer Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids Hum Mol Genet 15 2006 1745 1756
46. A.P. Simopoulos Genetic variants in the metabolism of omega-6 and omega-3 fatty acids: their role in the determination of nutritional requirements and chronic disease risk Exp Biol Med 235 2010 785 795
47. A.P. Simopoulos Evolutionary aspects of diet: the omega-6/omega-3 ratio and the brain Mol Neurobiol 44 2011 203 215
48. D. Tassoni, G. Kaur, R.S. Weisinger, and A.J. Sinclair The role of eicosanoids in the brain Asia-Pac J Clin Nutr 17 2008 220 228
49. H. Tapiero, G.N. Ba, P. Couvreur, and K.D. Tew Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies Biomed Pharmacother 56 2002 215 222
50. J.L. Breslow N-3 fatty acids and cardiovascular disease Am J Clin Nutr 83 2006 1477S 1482S
51. P.M. Kris-Etherton, W.S. Harris, and L.J. Appel Committee ftAN. Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association Arterioscler Thromb Vasc Biol 23 2003 151 152
52. D. Mozaffarian, and J.H. Wu (n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary? J Nutr 142 2012 614S 625S
53. S. Chalon Omega-3 fatty acids and monoamine neurotransmission Prostaglandins Leukot Essent Fatty Acids 75 2006 259 269
54. J.M. Bourre, G. Pascal, G. Durand, M. Masson, O. Dumont, and M. Piciotti Alterations in the fatty-acid composition of rat-brain cells (neurons, astrocytes, and oligodendrocytes) and of subcellular-fractions (myelin and synaptosomes) induced by a diet devoid of n-3 fatty-acids J Neurochem 43 1984 342 348
55. T. Moriguchi, and N. Salem Recovery of brain docosahexaenoate leads to recovery of spatial task performance J Neurochem 87 2003 297 309
56. B. Levant, J.D. Radel, and S.E. Carlson Decreased brain docosahexaenoic acid during development alters dopamine-related behaviors in adult rats that are differentially affected by dietary remediation Behav Brain Res 152 2004 49 57
57. M. Umezawa, A. Ohta, H. Tojo, H. Yagi, M. Hosokawa, and T. Takeda Dietary alpha-linolenate/linoleate balance influences learning and memory in the senescence-accelerated mouse (SAM) Brain Res 669 1995 225 233
58. J.J. Kooij, J.K. Buitelaar, E.J. van den Oord, J.W. Furer, C.A. Rijnders, and P.P. Hodiamont Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults Psychol Med 35 2005 817 827
59. S. Chalon The role of fatty acids in the treatment of ADHD Neuropharmacology 57 2009 636 639
60. D.W. Luchtman, and C. Song Cognitive enhancement by omega-3 fatty acids from child-hood to old age: findings from animal and clinical studies Neuropharmacology 64 2013 550 565
61. V.K. Sidhu, B.X. Huang, and H.Y. Kim Effects of docosahexaenoic acid on mouse brain synaptic plasma membrane proteome analyzed by mass spectrometry and O-16/O-18 labeling J Proteome Res 10 2011 5472 5480
62. D.H. Cao, K. Kevala, J. Kim, H.S. Moon, S.B. Jun, and D. Lovinger Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function J Neurochem 111 2009 510 521
63. S.C. Dyall, G.J. Michael, and A.T. Michael-Titus Omega-3 fatty acids reverse age-related decreases in nuclear receptors and increase neurogenesis in old rats J Neurosci Res 88 2010 2091 2102
64. S.C. Dyall, and A.T. Michael-Titus Neurological benefits of omega-3 fatty acids NeuroMol Med 10 2008 219 235
65. K. Kitajka, A.J. Sinclair, R.S. Weisinger, H.S. Weisinger, M. Mathai, and A.P. Jayasooriya Effects of dietary omega-3 polyunsaturated fatty acids on brain gene expression Proc Nat Acad Sci USA 101 2004 10931 10936
66. R. Wall, R.P. Ross, G.F. Fitzgerald, and C. Stanton Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids Nutr Rev 68 2010 280 289
67. E. Hjorth, and Y. Freund-Levi Immunomodulation of microglia by docosahexaenoic acid and eicosapentaenoic acid Curr Opin Clin Nutr Metab Care 15 2012 134 143
68. M. Makrides, R.A. Gibson, A.J. McPhee, L. Yelland, J. Quinlivan, and P. Ryan Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial JAMA 304 2010 1675 1683
69. E.B. Isaacs, S. Ross, K. Kennedy, L.T. Weaver, A. Lucas, and M.S. Fewtrell 10-year cognition in preterms after random assignment to fatty acid supplementation in infancy Pediatrics 128 2011 e890 e898
70. L.G. Smithers, C.T. Collins, L.A. Simmonds, R.A. Gibson, A. McPhee, and M. Makrides Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow-up study of a randomized controlled trial Am J Clin Nutr 91 2010 628 634
71. M.S. Fewtrell, R.A. Abbott, K. Kennedy, A. Singhal, R. Morley, and E. Caine Randomized, double-blind trial of long-chain polyunsaturated fatty acid supplementation with fish oil and borage oil in preterm infants J Pediatr 144 2004 471 479
72. M.S. Fewtrell, R. Morley, R.A. Abbott, A. Singhal, E.B. Isaacs, and T. Stephenson Double-blind, randomized trial of long-chain polyunsaturated fatty acid supplementation in formula fed to preterm infants Pediatrics 110 2002 73 82
73. A.C. Westerberg, R. Schei, C. Henriksen, L. Smith, M.B. Veierod, and C.A. Drevon Attention among very low birth weight infants following early supplementation with docosahexaenoic and arachidonic acid Acta Paediatr 100 2011 47 52
74. C. Henriksen, K. Haugholt, M. Lindgren, A.K. Aurvag, A. Ronnestad, and M. Gronn Improved cognitive development among preterm infants attributable to early supplementation of human milk with docosahexaenoic acid and arachidonic acid Pediatrics 121 2008 1137 1145
75. L.G. Smithers, R.A. Gibson, A. McPhee, and M. Makrides Higher dose of docosahexaenoic acid in the neonatal period improves visual acuity of preterm infants: results of a randomized controlled trial Am J Clin Nutr 88 2008 1049 1056
76. P.C. Fang, H.K. Kuo, C.B. Huang, T.Y. Ko, C.C. Chen, and M.Y. Chung The effect of supplementation of docosahexaenoic acid and arachidonic acid on visual acuity and neurodevelopment in larger preterm infants Chang Gung Med J 28 2005 708 715
77. D.L. O'Connor, R. Hall, D. Adamkin, N. Auestad, M. Castillo, and W.E. Connor Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: a prospective, randomized controlled trial Pediatrics 108 2001 359 371
78. M.M. Foreman-van Drongelen, A.C. Houwelingen, A.D. Kester, A.E. de Jong, C.E. Blanco, and T.H. Hasaart Long-chain polyene status of preterm infants with regard to the fatty acid composition of their diet: comparison between absolute and relative fatty acid levels in plasma and erythrocyte phospholipids Br J Nutr 73 1995 405 422
79. P.J. Aggett, F. Haschke, W. Heine, O. Hernell, B. Koletzko, and K. Launiala Comment on the content and composition of lipids in infant formulas. ESPGAN Committee on Nutrition Acta Paediatrica Scandinavica 80 1991 887 896
80. S.E. Carlson, R.J. Cooke, P.G. Rhodes, J.M. Peeples, S.H. Werkman, and E.A. Tolley Long-term feeding of formulas high in linolenic acid and marine oil to very low birth weight infants: phospholipid fatty acids Pediatr Res 30 1991 404 412
81. S.E. Carlson, P.G. Rhodes, V.S. Rao, and D.E. Goldgar Effect of fish oil supplementation on the n-3 fatty acid content of red blood cell membranes in preterm infants Pediatr Res 21 1987 507 510
82. M.T. Clandinin, A. Parrott, J.E. Van Aerde, A.R. Hervada, and E. Lien Feeding preterm infants a formula containing C20 and C22 fatty acids simulates plasma phospholipid fatty acid composition of infants fed human milk Early Human Dev 31 1992 41 51
83. B. Koletzko, E. Schmidt, H.J. Bremer, M. Haug, and G. Harzer Effects of dietary long-chain polyunsaturated fatty acids on the essential fatty acid status of premature infants Eur J Pediatr 148 1989 669 675
84. S.E. Carlson Arachidonic acid status of human infants: influence of gestational age at birth and diets with very long chain n-3 and n-6 fatty acids J Nutr 126 1996 1092S 1098S
85. S.A. van Goor, D.A.J. Dijck-Brouwer, J.J.H.M. Erwich, A. Schaafsma, and M. Hadders-Algra The influence of supplemental docosahexaenoic and arachidonic acids during pregnancy and lactation on neurodevelopment at eighteen months Prostaglandins Leukot Essent Fatty Acids 84 2011 139 146
86. A. Firmansyah, P.G. Dwipoerwantoro, M. Kadim, S. Alatas, N. Conus, and L. Lestarina Improved growth of toddlers fed a milk containing synbiotics Asia-Pac J Clin Nutr 20 2011 69 76
87. L.G. Smithers, R.A. Gibson, and M. Makrides Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial Am J Clin Nutr 93 2011 1293 1299
88. C. de Jong, H.K. Kikkert, V. Fidler, and M. Hadders-Algra The Groningen LCPUFA study: no effect of postnatal long-chain polyunsaturated fatty acids in healthy term infants on neurological condition at 9 years Br J Nutr 104 2010 566 572
89. E.E. Birch, S.E. Carlson, D.R. Hoffman, K.M. Fitzgerald-Gustafson, V.L. Fu, and J.R. Drover The DIAMOND (DHA intake and measurement of neural development) study: a double-masked, randomized controlled clinical trial of the maturation of infant visual acuity as a function of the dietary level of docosahexaenoic acid Am J Clin Nutr 91 2010 848 859
90. R.T. Pivik, R.A. Dykman, H. Jing, J.M. Gilchrist, and T.M. Badger Early infant diet and the omega 3 fatty acid DHA: effects on resting cardiovascular activity and behavioral development during the first half-year of life Dev Neuropsychol 34 2009 139 158
91. J.A. Dunstan, K. Simmer, G. Dixon, and S.L. Prescott Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial Arch Dis Child 93 2008 F45 F50
92. S.M. Innis, and R.W. Friesen Essential n-3 fatty acids in pregnant women and early visual acuity maturation in term infants Am J Clin Nutr 87 2008 548 557
93. M.P. Judge, O. Harel, and C.J. Lammi-Keefe A docosahexaenoic acid-functional food during pregnancy benefits infant visual acuity at four but not six months of age Lipids 42 2007 117 122
94. M.P. Judge, O. Harel, and C.J. Lammi-Keefe Maternal consumption of a docosahexaenoic acid-containing functional food during pregnancy: benefit for infant performance on problem-solving but not on recognition memory tasks at age 9 mo Am J Clin Nutr 85 2007 1572 1577
95. H. Bouwstra, J. Dijck-Brouwer, T. Decsi, G. Boehm, E.R. Boersma, and F.A. Muskiet Neurologic condition of healthy term infants at 18 months: positive association with venous umbilical DHA status and negative association with umbilical trans-fatty acids Pediatr Res 60 2006 334 339
96. C.L. Jensen, R.G. Voigt, T.C. Prager, Y.L. Zou, J.K. Fraley, and J.C. Rozelle Effects of maternal docosahexaenoic acid intake on visual function and neurodevelopment in breastfed term infants Am J Clin Nutr 82 2005 125 132
97. L. Lauritzen, M.H. Jorgensen, S.F. Olsen, E.M. Straarup, and K.F. Michaelsen Maternal fish oil supplementation in lactation: effect on developmental outcome in breast-fed infants Reprod Nutr Dev 45 2005 535 547
98. N. Auestad, D.T. Scott, J.S. Janowsky, C. Jacobsen, R.E. Carroll, and M.B. Montalto Visual, cognitive, and language assessments at 39 months: a follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1 year of age Pediatrics 112 2003 e177 e183
99. D.R. Hoffman, E.E. Birch, Y.S. Castaneda, S.L. Fawcett, D.H. Wheaton, and D.G. Birch Visual function in breast-fed term infants weaned to formula with or without long-chain polyunsaturates at 4 to 6 months: a randomized clinical trial J Pediatr 142 2003 669 677
100. C.A. Malcolm, D.L. McCulloch, C. Montgomery, A. Shepherd, and L.T. Weaver Maternal docosahexaenoic acid supplementation during pregnancy and visual evoked potential development in term infants: a double blind, prospective, randomised trial Arch Dis Child 88 2003 F383 F390
101. N. Auestad, R. Halter, R.T. Hall, M. Blatter, M.L. Bogle, and W. Burks Growth and development in term infants fed long-chain polyunsaturated fatty acids: a double-masked, randomized, parallel, prospective, multivariate study Pediatrics 108 2001 372 381
102. A. Lucas, M. Stafford, R. Morley, R. Abbott, T. Stephenson, and U. MacFadyen Efficacy and safety of long-chain polyunsaturated fatty acid supplementation of infant-formula milk: a randomised trial Lancet 354 1999 1948 1954
103. M. Horby Jorgensen, G. Holmer, P. Lund, O. Hernell, and K.F. Michaelsen Effect of formula supplemented with docosahexaenoic acid and gamma-linolenic acid on fatty acid status and visual acuity in term infants J Pediatr Gastroenterol Nutr 26 1998 412 421
104. D.T. Scott, J.S. Janowsky, R.E. Carroll, J.A. Taylor, N. Auestad, and M.B. Montalto Formula supplementation with long-chain polyunsaturated fatty acids: are there developmental benefits? Pediatrics 102 1998 E59
105. P. Willatts, S. Forsyth, C. Agostoni, P. Casaer, E. Riva, and G. Boehm Effects of long-chain PUFA supplementation in infant formula on cognitive function in later childhood Am J Clin Nutr 98 2013 536S 542S
106. E.E. Birch, S. Garfield, Y. Castaneda, D. Hughbanks-Wheaton, R. Uauy, and D. Hoffman Visual acuity and cognitive outcomes at 4 years of age in a double-blind, randomized trial of long-chain polyunsaturated fatty acid-supplemented infant formula Early Human Dev 83 2007 279 284
107. E.E. Birch, S. Garfield, D.R. Hoffman, R. Uauy, and D.G. Birch A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants Dev Med Child Neurol 42 2000 174 181
108. B. Koletzko, C. Agostoni, S.E. Carlson, T. Clandinin, G. Hornstra, and M. Neuringer Long chain polyunsaturated fatty acids (LC-PUFA) and perinatal development Acta Paediatr 90 2001 460 464
109. M. Hadders-Algra Prenatal and early postnatal supplementation with long-chain polyunsaturated fatty acids: neurodevelopmental considerations Am J Clin Nutr 94 2011 1874S 1879S
110. S.J. Meldrum, M.A. Smith, S.L. Prescott, K. Hird, and K. Simmer Achieving definitive results in long-chain polyunsaturated fatty acid supplementation trials of term infants: factors for consideration Nutr Rev 69 2011 205 214
111. K. Simmer, S.K. Patole, and S.C. Rao Long-chain polyunsaturated fatty acid supplementation in infants born at term Cochrane Database Syst Rev 12 2011 CD000376
112. A. Lapillonne, S. Groh-Wargo, C.H. Lozano Gonzalez, and R. Uauy Lipid needs of preterm infants: updated recommendations J Pediatr 162 2013 052
113. A. Eilander, D.C. Hundscheid, S.J. Osendarp, C. Transler, and P.L. Zock Effects of n-3 long chain polyunsaturated fatty acid supplementation on visual and cognitive development throughout childhood: a review of human studies Prostaglandins Leukot Essent Fatty Acids 76 2007 189 203
114. S. Aid, S. Vancassel, C. Poumes-Ballihaut, S. Chalon, P. Guesnet, and M. Lavialle Effect of a diet-induced n-3 PUFA depletion on cholinergic parameters in the rat hippocampus J Lipid Res 44 2003 1545 1551
115. T. Moriguchi, R.S. Greiner, and N. Salem Jr. Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration J Neurochem 75 2000 2563 2573
116. G.P. Amminger, G.E. Berger, M.R. Schafer, C. Klier, M.H. Friedrich, and M. Feucht Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study Biol Psychiatry 61 2007 551 553
117. S. Bent, K. Bertoglio, P. Ashwood, A. Bostrom, and R.L. Hendren A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder J Autism Dev Disord 41 2011 545 554
118. N.A. Meguid, H.M. Atta, A.S. Gouda, and R.O. Khalil Role of polyunsaturated fatty acids in the management of Egyptian children with autism Clin Biochem 41 2008 1044 1048
119. P. Politi, H. Cena, M. Comelli, G. Marrone, C. Allegri, and E. Emanuele Behavioral effects of omega-3 fatty acid supplementation in young adults with severe autism: an open label study Arch Med Res 39 2008 682 685
120. K. Yui, M. Koshiba, S. Nakamura, and Y. Kobayashi Effects of large doses of arachidonic acid added to docosahexaenoic acid on social impairment in individuals with autism spectrum disorders: a double-blind, placebo-controlled, randomized trial J Clin Psychopharmacol 32 2012 200 206
121. D. Gillies, J. Sinn, S.S. Lad, M.J. Leach, and M.J. Ross Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents Cochrane Database Syst Rev 7 2012 CD007986
122. S. James, P. Montgomery, and K. Williams Omega-3 fatty acids supplementation for autism spectrum disorders (ASD) Cochrane Database Syst Rev 11 2011 CD007992
123. S.A. Belanger, M. Vanasse, S. Spahis, M.P. Sylvestre, S. Lippe, and F. L'Heureux Omega-3 fatty acid treatment of children with attention-deficit hyperactivity disorder: a randomized, double-blind, placebo-controlled study Paediatrics Child Health 14 2009 89 98
124. P.A. Gustafsson, U. Birberg-Thornberg, K. Duchen, M. Landgren, K. Malmberg, and H. Pelling EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD Acta Paediatr 99 2010 1540 1549
125. S. Hirayama, T. Hamazaki, and K. Terasawa Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/ hyperactivity disorder - a placebo-controlled double-blind study Eur J Clin Nutr 58 2004 467 473
126. M. Johnson, S. Ostlund, G. Fransson, B. Kadesjo, and C. Gillberg Omega-3/omega-6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo-controlled trial in children and adolescents J Atten Disord 12 2009 394 401
127. C.M. Milte, N. Parletta, J.D. Buckley, A.M. Coates, R.M. Young, and P.R. Howe Eicosapentaenoic and docosahexaenoic acids, cognition, and behavior in children with attention-deficit/hyperactivity disorder: a randomized controlled trial Nutrition 28 2012 670 677
128. H. Perera, K.C. Jeewandara, S. Seneviratne, and C. Guruge Combined omega3 and omega6 supplementation in children with attention-deficit hyperactivity disorder (ADHD) refractory to methylphenidate treatment: a double-blind, placebo-controlled study J Child Neurol 27 2012 747 753
129. R. Raz, R.L. Carasso, and S. Yehuda The influence of short-chain essential fatty acids on children with attention-deficit/hyperactivity disorder: a double-blind placebo-controlled study J Child Adolesc Psychopharmacol 19 2009 167 177
130. P.J. Sorgi, E.M. Hallowell, H.L. Hutchins, and B. Sears Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder Nutr J 6 2007 16
131. R.G. Voigt, A.M. Llorente, C.L. Jensen, J.K. Fraley, M.C. Berretta, and W.C. Heird A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/ hyperactivity disorder J Pediatr 139 2001 189 196
132. G.M. Cole, Q.L. Ma, and S.A. Frautschy Omega-3 fatty acids and dementia Prostaglandins Leukot Essent Fatty Acids 81 2009 213 221
133. A. Wu, Z. Ying, and F. Gomez-Pinilla Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition Neuroscience 155 2008 751 759
134. R.J. Wurtman Synapse formation and cognitive brain development: effect of docosahexaenoic acid and other dietary constituents Metabolism 57 Suppl. 2 2008 S6 S10
135. R. Agrawal, and F. Gomez-Pinilla 'Metabolic syndrome' in the brain: deficiency in omega-3 fatty acid exacerbates dysfunctions in insulin receptor signalling and cognition J Physiol 590 2012 2485 2499
136. L. Moretti, I. Cristofori, S.M. Weaver, A. Chau, J.N. Portelli, and J. Grafman Cognitive decline in older adults with a history of traumatic brain injury Lancet Neurol 11 2012 1103 1112
137. E. Masliah, L. Crews, and L. Hansen Synaptic remodeling during aging and in Alzheimer's disease J Alzheimers Dis 9 2006 91 99
138. E. Masliah, M. Mallory, L. Hansen, M. Alford, R. Deteresa, and R. Terry An antibody against phosphorylated neurofilaments identifies a subset of damaged association axons in Alzheimers-disease Am J Pathol 142 1993 871 882
139. D.R. Brown Role of microglia in age-related changes to the nervous system Sci World J 9 2009 1061 1071
140. N. Raz, F.M. Gunning, D. Head, J.H. Dupuis, J. McQuain, and S.D. Briggs Selective aging of the human cerebral cortex observed in vivo: differential vulnerability of the prefrontal gray matter Cereb Cortex 7 1997 268 282
141. D.J. Tisserand, J.C. Pruessner, E.J.S. Arigita, M.P.J. van Boxtel, A.C. Evans, and J. Jolles Regional frontal cortical volumes decrease differentially in aging: an MRI study to compare volumetric approaches and voxel-based morphometry Neuroimage 17 2002 657 669
142. D.H. Salat, J.A. Kaye, and J.S. Janowsky Prefrontal gray and white matter volumes in healthy aging and Alzheimer disease Arch Neurol 56 1999 338 344
143. O. van de Rest, J.M. Geleijnse, F.J. Kok, W.A. van Staveren, C. Dullemeijer, and M.G. Olderikkert Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial Neurology 71 2008 430 438
144. R.B. Singh, S. Gupta, P. Dherange, F. De Meester, A. Wilczynska, and S.E. Alam Metabolic syndrome: a brain disease Can J Physiol Pharmacol 90 2012 1171 1183
145. Diet, nutrition and the prevention of chronic diseases. World Health Organization technical report series. 2003;916:i-viii, 1-149, backcover.
146. A.M. Jenner, W.L. Lim, M.P. Ng, M.R. Wenk, G. Shui, and M.J. Sharman The effect of APOE genotype on brain levels of oxysterols in young and old human APOE epsilon2, epsilon3 and epsilon4 knock-in mice Neuroscience 169 2010 109 115
147. J.E. Donahue, and C.E. Johanson Apolipoprotein E, Amyloid-beta, and blood-brain barrier permeability in Alzheimer disease J Neuropathol Exp Neurol 67 2008 261 270
148. P. Libby, A.H. Lichtman, and G.K. Hansson Immune effector mechanisms implicated in atherosclerosis: from mice to humans Immunity 38 2013 1092 1104
149. M.N. Haan, and R. Wallace Can dementia be prevented? Brain aging in a population-based context Annu Rev Public Health 25 2004 1 24
150. L.J. Launer, and A. Hofman Frequency and impact of neurologic diseases in the elderly of Europe: a collaborative study of population-based cohorts Neurology 54 2000 S1 S8
151. A. Ruitenberg, I. Skoog, A. Ott, O. Aevarsson, J.C. Witteman, and B. Lernfelt Blood pressure and risk of dementia: results from the Rotterdam study and the Gothenburg H-70 Study Dement Geriatr Cogn Disord 12 2001 33 39
152. I. Skoog, and D. Gustafson Update on hypertension and Alzheimer's disease Neurol Res 28 2006 605 611
153. J.C. de la Torre A turning point for Alzheimer's disease? BioFactors 38 2012 78 83
154. R.N. Kalaria, R. Akinyemi, and M. Ihara Does vascular pathology contribute to Alzheimer changes? J Neurol Sci 322 2012 141 147
155. P. Grammas, M. Yamada, and B. Zlokovic The cerebromicrovasculature: a key player in the pathogenesis of Alzheimer's disease J Alzheimers Dis 4 2002 217 223
156. M. Muller, M.X. Tang, N. Schupf, J.J. Manly, R. Mayeux, and J.A. Luchsinger Metabolic syndrome and dementia risk in a multiethnic elderly cohort Dement Geriatr Cogn Disord 24 2007 185 192
157. F.B. Hu, L. Bronner, W.C. Willett, M.J. Stampfer, K.M. Rexrode, and C.M. Albert Fish and omega-3 fatty acid intake and risk of coronary heart disease in women JAMA 287 2002 1815 1821
158. F. Thies, J.M. Garry, P. Yaqoob, K. Rerkasem, J. Williams, and C.P. Shearman Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial Lancet 361 2003 477 485
159. A. Leaf, J.X. Kang, Y.F. Xiao, and G.E. Billman Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils Circulation 107 2003 2646 2652
160. J.M. Geleijnse, E.J. Giltay, D.E. Grobbee, A.R. Donders, and F.J. Kok Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials J Hypertens 20 2002 1493 1499
161. J. Goodfellow, M.F. Bellamy, M.W. Ramsey, C.J. Jones, and M.J. Lewis Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia J Am Coll Cardiol 35 2000 265 270
162. W.S. Harris, G. Lu, G.S. Rambjor, A.I. Walen, J.A. Ontko, and Q. Cheng Influence of n-3 fatty acid supplementation on the endogenous activities of plasma lipases Am J Clin Nutr 66 1997 254 260
163. C. von Schacky, and W.S. Harris Cardiovascular risk and the omega-3 index J Cardiovasc Med (Hagerstown, Md) 8 Suppl. 1 2007 S46 S49
164. P.C. Calder, and P. Yaqoob Omega-3 (n-3) fatty acids, cardiovascular disease and stability of atherosclerotic plaques Cell Mol Biol 56 2010 28 37
165. H.O. Bang, J. Dyerberg, and N. Hjoorne The composition of food consumed by Greenland Eskimos Acta Medica Scandinavica 200 1976 69 73
166. J. Dyerberg, and H.O. Bang Lipid metabolism, atherogenesis, and haemostasis in Eskimos: the role of the prostaglandin-3 family Haemostasis 8 1979 227 233
167. K. He, Y. Song, M.L. Daviglus, K. Liu, L. Van Horn, and A.R. Dyer Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies Circulation 109 2004 2705 2711
168. W.E. Connor Importance of n-3 fatty acids in health and disease Am J Clin Nutr 71 2000 171S 175S
169. N. Okuda, H. Ueshima, A. Okayama, S. Saitoh, H. Nakagawa, and B.L. Rodriguez Relation of long chain n-3 polyunsaturated fatty acid intake to serum high density lipoprotein cholesterol among Japanese men in Japan and Japanese-American men in Hawaii: the INTERLIPID study Atherosclerosis 178 2005 371 379
170. F. Sofi, G. Giorgi, F. Cesari, A.M. Gori, L. Mannini, and G. Parisi The atherosclerotic risk profile is affected differently by fish flesh with a similar EPA and DHA content but different n-6/n-3 ratio Asia-Pac J Clin Nutr 22 2013 32 40
171. A.V. Witte, L. Kerti, H.M. Hermannstadter, J.B. Fiebach, S.J. Schreiber, and J.P. Schuchardt Long-chain omega-3 fatty acids improve brain function and structure in older adults Cereb Cortex 2013 10.1093/cercor/bht163
172. K. Yurko-Mauro, D. McCarthy, D. Rom, E.B. Nelson, A.S. Ryan, and A. Blackwell Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline Alzheimers Dement 6 2010 456 464
173. C. Stough, L. Downey, B. Silber, J. Lloyd, C. Kure, and K. Wesnes The effects of 90-day supplementation with the omega-3 essential fatty acid docosahexaenoic acid (DHA) on cognitive function and visual acuity in a healthy aging population Neurobiol Aging 33 824 2012 e1 e3
174. A.D. Dangour, E. Allen, D. Elbourne, N. Fasey, A.E. Fletcher, and P. Hardy Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial Am J Clin Nutr 91 2010 1725 1732
175. V. Danthiir, N.R. Burns, T. Nettelbeck, C. Wilson, and G. Wittert The older people, omega-3, and cognitive health (EPOCH) trial design and methodology: a randomised, double-blind, controlled trial investigating the effect of long-chain omega-3 fatty acids on cognitive ageing and wellbeing in cognitively healthy older adults Nutr J 10 2011 117
176. C.C. Chiu, K.P. Su, T.C. Cheng, H.C. Liu, C.J. Chang, and M.E. Dewey The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study Prog Neuropsychopharmacol Biol Psychiatry 32 2008 1538 1544
177. N. Sinn, C.M. Milte, S.J. Street, J.D. Buckley, A.M. Coates, and J. Petkov Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial Br J Nutr 107 2012 1682 1693
178. L.K. Lee, S. Shahar, A.V. Chin, and N.A. Yusoff Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial Psychopharmacology 225 2013 605 612
179. V.A. Andreeva, E. Kesse-Guyot, P. Barberger-Gateau, L. Fezeu, S. Hercberg, and P. Galan Cognitive function after supplementation with B vitamins and long-chain omega-3 fatty acids: ancillary findings from the SU.FOL.OM3 randomized trial Am J Clin Nutr 94 2011 278 286
180. T. Terano, S. Fujishiro, T. Ban, K. Yamamoto, T. Tanaka, and Y. Noguchi Docosahexaenoic acid supplementation improves the moderately severe dementia from thrombotic cerebrovascular diseases Lipids 34 Suppl 1999 S345 S346
181. R.N. Kalaria Vascular basis for brain degeneration: faltering controls and risk factors for dementia Nutr Rev 68 2010 S74 S87
182. C.R. Wendell, S.R. Waldstein, L. Ferrucci, R.J. O'Brien, J.B. Strait, and A.B. Zonderman Carotid atherosclerosis and prospective risk of dementia Stroke 43 2012 3319 3324
183. M. Yarchoan, S.X. Xie, M.A. Kling, J.B. Toledo, D.A. Wolk, and E.B. Lee Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias Brain 135 2012 3749 3756
184. C. Qiu Preventing Alzheimer's disease by targeting vascular risk factors: hope and gap J Alzheimers Dis 32 2012 721 731
185. J.A. Conquer, M.C. Tierney, J. Zecevic, W.J. Bettger, and R.H. Fisher Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment Lipids 35 2000 1305 1312
186. A. Ikemoto, M. Ohishi, Y. Sato, N. Hata, Y. Misawa, and Y. Fujii Reversibility of n-3 fatty acid deficiency-induced alterations of learning behavior in the rat: level of n-6 fatty acids as another critical factor J Lipid Res 42 2001 1655 1663
187. D.J. Kyle, E. Schaefer, G. Patton, and A. Beiser Low serum docosahexaenoic acid is a significant risk factor for Alzheimer's dementia Lipids 34 Suppl 1999 S245
188. E. Freemantle, M. Vandal, J. Tremblay-Mercier, S. Tremblay, J.C. Blachere, and M.E. Begin Omega-3 fatty acids, energy substrates, and brain function during aging Prostaglandins Leukot Essent Fatty Acids 75 2006 213 220
189. K. Yurko-Mauro Cognitive and cardiovascular benefits of docosahexaenoic acid in aging and cognitive decline Curr Alzheimer Res 7 2010 190 196
190. Y. Kiso Pharmacology in health foods: effects of arachidonic acid and docosahexaenoic acid on the age-related decline in brain and cardiovascular system function J Pharmacol Sci 115 2011 471 475
191. J.M. Bourre Dietary omega-3 fatty acids for women Biomed Pharmacother 61 2007 105 112
192. K.N. Green, H. Martinez-Coria, H. Khashwji, E.B. Hall, K.A. Yurko-Mauro, and L. Ellis Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels J Neurosci 27 2007 4385 4395
193. K.N. Green, I.F. Smith, and F.M. Laferla Role of calcium in the pathogenesis of Alzheimer's disease and transgenic models Subcell Biochem 45 2007 507 521
194. I. Fedorova, and N. Salem Jr. Omega-3 fatty acids and rodent behavior Prostaglandins Leukot Essent Fatty Acids 75 2006 271 289
195. C.R. Hooijmans, C.E. Van der Zee, P.J. Dederen, K.M. Brouwer, Y.D. Reijmer, and T. van Groen DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice Neurobiol Dis 33 2009 482 498
196. F. Calon, G.P. Lim, F. Yang, T. Morihara, B. Teter, and O. Ubeda Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model Neuron 43 2004 633 645
197. G.M. Cole, and S.A. Frautschy Docosahexaenoic acid protects from amyloid and dendritic pathology in an Alzheimer's disease mouse model Nutr Health 18 2006 249 259
198. Y. Zhao, F. Calon, C. Julien, J.W. Winkler, N.A. Petasis, and W.J. Lukiw Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARgamma-mediated mechanisms in Alzheimer's disease models PLoS ONE 6 2011 e15816
199. N.G. Bazan, M.F. Molina, and W.C. Gordon Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases Annu Rev Nutr 31 2011 321 351
200. G.A. Jicha, and W.R. Markesbery Omega-3 fatty acids: potential role in the management of early Alzheimer's disease Clin Interv Aging 5 2010 45 61
201. G. Siegel, and E. Ermilov Omega-3 fatty acids: benefits for cardio-cerebro-vascular diseases Atherosclerosis 225 2012 291 295
202. F. Calon Omega-3 polyunsaturated fatty acids in Alzheimer's disease: key questions and partial answers Curr Alzheimer Res 8 2011 470 478
203. T. Cederholm, and J. Palmblad Are omega-3 fatty acids options for prevention and treatment of cognitive decline and dementia? Curr Opin Clin Nutr Metabol Care 13 2010 150 155
204. E.K. Pauwels, D. Volterrani, G. Mariani, and K. Kairemo Fatty acid facts, Part IV: docosahexaenoic acid and Alzheimer's disease. A story of mice, men and fish Drug News Perspect 22 2009 205 213
205. N. Scarmeas, Y. Stern, M.X. Tang, R. Mayeux, and J.A. Luchsinger Mediterranean diet and risk for Alzheimer's disease Ann Neurol 59 2006 912 921
206. N. Scarmeas, J.A. Luchsinger, R. Mayeux, and Y. Stern Mediterranean diet and Alzheimer disease mortality Neurology 69 2007 1084 1093
207. V. Frisardi, F. Panza, D. Seripa, B.P. Imbimbo, G. Vendemiale, and A. Pilotto Nutraceutical properties of Mediterranean diet and cognitive decline: possible underlying mechanisms J Alzheimers Dis 22 2010 715 740
208. Y. Gu, J.A. Luchsinger, Y. Stern, and N. Scarmeas Mediterranean diet, inflammatory and metabolic biomarkers, and risk of Alzheimer's disease J Alzheimers Dis 22 2010 483 492
209. E.R. Dorsey, R. Constantinescu, J.P. Thompson, K.M. Biglan, R.G. Holloway, and K. Kieburtz Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030 Neurology 68 2007 384 386
210. T.T. Warner, and A.H. Schapira Genetic and environmental factors in the cause of Parkinson's disease Ann Neurol 53 Suppl. 3 2003 S16 S23 [discussion S-5]
211. A. Samii, J.G. Nutt, and B.R. Ransom Parkinson's disease The Lancet 363 2004 1783 1793
212. R. Desouza, E. Moro, A. Lang, and A. Schapira Timing of deep brain stimulation in Parkinson's disease: a need for reappraisal? Ann Neurol 8 2013 23890
213. A.L. Spieles-Engemann, M.M. Behbehani, T.J. Collier, S.L. Wohlgenant, K. Steece-Collier, and K. Paumier Stimulation of the rat subthalamic nucleus is neuroprotective following significant nigral dopamine neuron loss Neurobiol Dis 39 2010 105 115
214. W.M. Schupbach, D. Maltete, J.L. Houeto, S.T. du Montcel, L. Mallet, and M.L. Welter Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial Neurology 68 2007 267 271
215. K. Nishimura, and J. Takahashi Therapeutic application of stem cell technology toward the treatment of Parkinson's disease Biol Pharm Bull 36 2013 171 175
216. G. Tanriover, Y. Seval-Celik, O. Ozsoy, G. Akkoyunlu, F. Savcioglu, and G. Hacioglu The effects of docosahexaenoic acid on glial derived neurotrophic factor and neurturin in bilateral rat model of Parkinson's disease Folia Histochem Cytobiol 48 2010 434 441
217. D. Miyazawa, Y. Yasui, K. Yamada, N. Ohara, and H. Okuyama Regional differences of the mouse brain in response to an alpha-linolenic acid-restricted diet: neurotrophin content and protein kinase activity Life Sci 87 2010 490 494
218. J.S. Rao, R.N. Ertley, H.J. Lee, J.C. DeMar Jr., J.T. Arnold, and S.I. Rapoport N-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism Mol Psychiatry 12 2007 36 46
219. M. Bousquet, C. Gibrat, M. Saint-Pierre, C. Julien, F. Calon, and F. Cicchetti Modulation of brain-derived neurotrophic factor as a potential neuroprotective mechanism of action of omega-3 fatty acids in a parkinsonian animal model Prog Neuropsychopharmacol Biol Psychiatry 33 2009 1401 1408
220. G. Hacioglu, Y. Seval-Celik, G. Tanriover, O. Ozsoy, E. Saka-Topcuoglu, and S. Balkan Docosahexaenoic acid provides protective mechanism in bilaterally MPTP-lesioned rat model of Parkinson's disease Folia Histochem Cytobiol 50 2012 228 238
221. O. Ozsoy, Y. Seval-Celik, G. Hacioglu, P. Yargicoglu, R. Demir, and A. Agar The influence and the mechanism of docosahexaenoic acid on a mouse model of Parkinson's disease Neurochem Int 59 2011 664 670
222. M. Bousquet, K. Gue, V. Emond, P. Julien, J.X. Kang, and F. Cicchetti Transgenic conversion of omega-6 into omega-3 fatty acids in a mouse model of Parkinson's disease J Lipid Res 52 2011 263 271
223. A. Ji, H. Diao, X. Wang, R. Yang, J. Zhang, and W. Luo N-3 polyunsaturated fatty acids inhibit lipopolysaccharide-induced microglial activation and dopaminergic injury in rats Neurotoxicology 33 2012 780 788
224. H.D. Cardoso, P.P. Passos, C.J. Lagranha, A.C. Ferraz, E.F. Santos Junior, and R.S. Oliveira Differential vulnerability of substantia nigra and corpus striatum to oxidative insult induced by reduced dietary levels of essential fatty acids Front Human Neurosci 6 2012 249
225. S. Mahmoudi, P. Samadi, F. Gilbert, B. Ouattara, M. Morissette, and L. Gregoire Nur77 mRNA levels and L-Dopa-induced dyskinesias in MPTP monkeys treated with docosahexaenoic acid Neurobiol Dis 36 2009 213 222
226. T.A. Mori, D.Q. Bao, V. Burke, I.B. Puddey, and L.J. Beilin Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans Hypertension 34 1999 253 260
227. K. Parain, M.G. Murer, Q. Yan, B. Faucheux, Y. Agid, and E. Hirsch Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra NeuroReport 10 1999 557 561
228. Y. Freund-Levi, M. Eriksdotter-Jonhagen, T. Cederholm, H. Basun, G. Faxen-Irving, and A. Garlind Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial Arch Neurol 63 2006 1402 1408
229. S. Kotani, E. Sakaguchi, S. Warashina, N. Matsukawa, Y. Ishikura, and Y. Kiso Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction Neurosci Res 56 2006 159 164
230. J.F. Quinn, R. Raman, R.G. Thomas, K. Yurko-Mauro, E.B. Nelson, and C. Van Dyck Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial JAMA 304 2010 1903 1911
231. P. Scheltens, J.W. Twisk, R. Blesa, E. Scarpini, C.A. von Arnim, and A. Bongers Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial J Alzheimers Dis 31 2012 225 236
232. P.F. Boston, A. Bennett, D.F. Horrobin, and C.N. Bennett Ethyl-EPA in Alzheimer's disease - a pilot study Prostaglandins Leukot Essent Fatty Acids 71 2004 341 346
233. T.M. da Silva, R.P. Munhoz, C. Alvarez, K. Naliwaiko, A. Kiss, and R. Andreatini Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation J Affect Disord 111 2008 351 359
234. S. Yehuda, S. Rabinovtz, R.L. Carasso, and D.I. Mostofsky Essential fatty acids preparation (SR-3) improves Alzheimer's patients quality of life Int J Neurosci 87 1996 141 149
235. G.W. Arendash, M.T. Jensen, N. Salem Jr., N. Hussein, J. Cracchiolo, and A. Dickson A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice Neuroscience 149 2007 286 302
236. D. Arsenault, C. Julien, C. Tremblay, and F. Calon DHA improves cognition and prevents dysfunction of entorhinal cortex neurons in 3xTg-AD mice PLoS ONE 6 2011 e17397
237. F. Calon, G.P. Lim, T. Morihara, F. Yang, O. Ubeda, and N. Salem Jr Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease Eur J Neurosci 22 2005 617 626
238. M. Hashimoto, S. Hossain, T. Shimada, and O. Shido Docosahexaenoic acid-induced protective effect against impaired learning in amyloid beta-infused rats is associated with increased synaptosomal membrane fluidity Clin Exp Pharmacol Physiol 33 2006 934 939
239. M. Oksman, H. Iivonen, E. Hogyes, Z. Amtul, B. Penke, and I. Leenders Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice Neurobiol Dis 23 2006 563 572
240. M. Cansev Uridine and cytidine in the brain: their transport and utilization Brain Res Rev 52 2006 389 397
241. R.J. Wurtman, M. Regan, I. Ulus, and L. Yu Effect of oral CDP-choline on plasma choline and uridine levels in humans Biochem Pharmacol 60 2000 989 992